Iovance Biotherapeutics, Inc. (IOVA) market cap

Market cap today
$3.48B

Iovance Biotherapeutics, Inc. (IOVA) has a market cap of $3.48B. At the end of fiscal 2025 (December 31, 2025) its market cap was $975.55M. That is 54.5% lower than the $2.15B of fiscal 2024. Today's figure is 257.1% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$3.48B
Market cap, fiscal 2025
$975.55M
Change on fiscal 2024
−54.5%
Growth, 5 years
−31.4% a year
Highest on record
$6.41Bfiscal 2020
Lowest on record
$975.55Mfiscal 2025
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Iovance Biotherapeutics, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 31.4% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $6.41B in fiscal 2020 and the lowest $975.55M in fiscal 2025.

History · 7 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Iovance Biotherapeutics, Inc. market cap, year by year

Iovance Biotherapeutics, Inc. (IOVA) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$3.48B—$7.53—
2025$975.55M 54.5% down$2.73357.35M
2024$2.15B 12.2% up$7.40289.88M
2023$1.91B 87.8% up$8.13235.13M
2022$1.02B 65.3% down$6.39159.26M
2021$2.93B 54.3% down$19.09153.48M
2020$6.41B 86.3% up$46.40138.08M
2019$3.44B—$27.68124.25M
2018——$8.85—
2017——$8.00—
2016——$6.95—
2015——$7.72—
2014——$7.87—
2013——$10.50—
2012——$22.00—
2011——$100.00—
2010——$125.00—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on IOVA

Iovance Biotherapeutics, Inc., figure by figure

Iovance Biotherapeutics, Inc. (IOVA) overview: price, valuation and scorecard

Iovance Biotherapeutics, Inc. market cap: questions and answers

What is Iovance Biotherapeutics, Inc.'s market cap?

Iovance Biotherapeutics, Inc. (IOVA) has a market cap of $3.48B. At the end of fiscal 2025 (December 31, 2025) its market cap was $975.55M. That is 54.5% lower than the $2.15B of fiscal 2024.

What is the growth rate of Iovance Biotherapeutics, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 31.4% a year.

What are the highest and lowest market cap figures on record for Iovance Biotherapeutics, Inc.?

Across the 7 fiscal year-ends on record (2019–2025), the highest was $6.41B in fiscal 2020 and the lowest $975.55M in fiscal 2025.

How is Iovance Biotherapeutics, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Iovance Biotherapeutics, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.